Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006518031-A |
titleOfInvention |
Methods for monitoring cancer prediction and prognosis, and cancer treatment |
abstract |
The invention also relates to the use of biomarkers and biomarkers for cancer prediction and prognosis and the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, the present invention relates to the use of adrenomedullin as a biomarker for Raf kinase inhibitors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013528809-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010504530-A |
priorityDate |
2002-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |